Glimtime-M2 Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP

The offered Glimtime-M2 Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP are the combination of glimepiride, an oral hypoglycaemic drug and metformin, an antihyperglycaemic drug, giving a synergistic effect for the management of Type 2 diabetes mellitus. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body’s sensitivity to insulin. The Glimtime-M2 Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP are very effective and useful.